rs2157257

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002473.6(MYH9):​c.1555-71T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.62 in 1,537,632 control chromosomes in the GnomAD database, including 309,404 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.52 ( 23360 hom., cov: 31)
Exomes 𝑓: 0.63 ( 286044 hom. )

Consequence

MYH9
NM_002473.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.344

Publications

12 publications found
Variant links:
Genes affected
MYH9 (HGNC:7579): (myosin heavy chain 9) This gene encodes a conventional non-muscle myosin; this protein should not be confused with the unconventional myosin-9a or 9b (MYO9A or MYO9B). The encoded protein is a myosin IIA heavy chain that contains an IQ domain and a myosin head-like domain which is involved in several important functions, including cytokinesis, cell motility and maintenance of cell shape. Defects in this gene have been associated with non-syndromic sensorineural deafness autosomal dominant type 17, Epstein syndrome, Alport syndrome with macrothrombocytopenia, Sebastian syndrome, Fechtner syndrome and macrothrombocytopenia with progressive sensorineural deafness. [provided by RefSeq, Dec 2011]
MYH9 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 17
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
  • May-Hegglin anomaly
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 22-36312293-A-G is Benign according to our data. Variant chr22-36312293-A-G is described in ClinVar as Benign. ClinVar VariationId is 1243503.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.67 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYH9NM_002473.6 linkc.1555-71T>C intron_variant Intron 13 of 40 ENST00000216181.11 NP_002464.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYH9ENST00000216181.11 linkc.1555-71T>C intron_variant Intron 13 of 40 1 NM_002473.6 ENSP00000216181.6

Frequencies

GnomAD3 genomes
AF:
0.518
AC:
78682
AN:
151896
Hom.:
23364
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.238
Gnomad AMI
AF:
0.763
Gnomad AMR
AF:
0.608
Gnomad ASJ
AF:
0.518
Gnomad EAS
AF:
0.221
Gnomad SAS
AF:
0.384
Gnomad FIN
AF:
0.652
Gnomad MID
AF:
0.516
Gnomad NFE
AF:
0.675
Gnomad OTH
AF:
0.541
GnomAD4 exome
AF:
0.631
AC:
874468
AN:
1385618
Hom.:
286044
AF XY:
0.626
AC XY:
432093
AN XY:
690724
show subpopulations
African (AFR)
AF:
0.224
AC:
7077
AN:
31620
American (AMR)
AF:
0.630
AC:
26812
AN:
42552
Ashkenazi Jewish (ASJ)
AF:
0.520
AC:
13088
AN:
25178
East Asian (EAS)
AF:
0.219
AC:
8514
AN:
38792
South Asian (SAS)
AF:
0.415
AC:
34654
AN:
83592
European-Finnish (FIN)
AF:
0.660
AC:
30792
AN:
46660
Middle Eastern (MID)
AF:
0.508
AC:
2836
AN:
5586
European-Non Finnish (NFE)
AF:
0.680
AC:
717056
AN:
1053980
Other (OTH)
AF:
0.583
AC:
33639
AN:
57658
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
15252
30504
45756
61008
76260
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17848
35696
53544
71392
89240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.518
AC:
78685
AN:
152014
Hom.:
23360
Cov.:
31
AF XY:
0.514
AC XY:
38164
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.238
AC:
9870
AN:
41468
American (AMR)
AF:
0.608
AC:
9289
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.518
AC:
1800
AN:
3472
East Asian (EAS)
AF:
0.221
AC:
1137
AN:
5152
South Asian (SAS)
AF:
0.385
AC:
1854
AN:
4810
European-Finnish (FIN)
AF:
0.652
AC:
6887
AN:
10566
Middle Eastern (MID)
AF:
0.520
AC:
153
AN:
294
European-Non Finnish (NFE)
AF:
0.675
AC:
45874
AN:
67952
Other (OTH)
AF:
0.536
AC:
1127
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1665
3330
4995
6660
8325
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
660
1320
1980
2640
3300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.599
Hom.:
4638
Bravo
AF:
0.504
Asia WGS
AF:
0.253
AC:
881
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 24, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Jul 15, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 89% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 83. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
4.8
DANN
Benign
0.73
PhyloP100
0.34
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2157257; hg19: chr22-36708338; COSMIC: COSV53395916; COSMIC: COSV53395916; API